Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""CYCLOSPORINE"" wg kryterium: Temat


Tytuł:
Rapidly Dissolving Trans-scleral Microneedles for Intraocular Delivery of Cyclosporine A.
Autorzy:
Alrbyawi H; Department of Drug Discovery and Development, Auburn University, Auburn, Alabama, USA.; Pharmaceutics and Pharmaceutical Technology Department, College of Pharmacy, Taibah University, Medina, Saudi Arabia.
Annaji M; Department of Drug Discovery and Development, Auburn University, Auburn, Alabama, USA.
Fasina O; Department of Biosystems Engineering, Samuel Ginn College of Engineering, Auburn University, Auburn, Alabama, 36849, USA.
Palakurthi S; Department of Pharmaceutical Sciences, Texas A&M University, Kingsville, Texas, USA.
Boddu SHS; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates.; Center of Medical and Bio-Allied Health Sciences Research, Ajman University, P.O. Box 346, Ajman, United Arab Emirates.
Hassan N; Center of Medical and Bio-Allied Health Sciences Research, Ajman University, P.O. Box 346, Ajman, United Arab Emirates. .; Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates. .
Tiwari AK; Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas of Medical Sciences, Little Rock, Arkansas, USA.
Suryawanshi A; Department of Pathobiology, College of Veterinary Medicine, Auburn University, 240B Greene Hall, Auburn, Alabama, 36849, USA.
Babu RJ; Department of Drug Discovery and Development, Auburn University, Auburn, Alabama, USA. .
Pokaż więcej
Źródło:
AAPS PharmSciTech [AAPS PharmSciTech] 2024 Feb 01; Vol. 25 (2), pp. 28. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Cyclosporine*
Eye*
Animals ; Swine ; Emulsions ; Immunosuppressive Agents ; Drug Delivery Systems
Czasopismo naukowe
Tytuł:
Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2.
Autorzy:
Guareschi F; ADDRes Lab, Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy.
Del Favero E; Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93, 20054 Milan, Italy.
Ricci C; Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93, 20054 Milan, Italy.
Cantù L; Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93, 20054 Milan, Italy.
Brandolini M; Unit of Microbiology, The Great Romagna Hub Laboratory, Piazza della Liberazione 60, 47522 Pievesestina, Italy.
Sambri V; Unit of Microbiology, The Great Romagna Hub Laboratory, Piazza della Liberazione 60, 47522 Pievesestina, Italy; Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum-University of Bologna, Via Massarenti 1, 40138 Bologna, Italy.
Nicoli S; ADDRes Lab, Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy.
Pescina S; ADDRes Lab, Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy.
D'Angelo D; ADDRes Lab, Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy.
Rossi I; Nanopharm Ltd, Franklin House, Grange Road, Cwmbran NP44 3WY, United Kingdom.
Buttini F; ADDRes Lab, Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy; Interdepartmental Center for Innovation in Health Products, Biopharmanet_TEC, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy.
Bettini R; ADDRes Lab, Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy; Interdepartmental Center for Innovation in Health Products, Biopharmanet_TEC, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy.
Sonvico F; ADDRes Lab, Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy; Interdepartmental Center for Innovation in Health Products, Biopharmanet_TEC, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy. Electronic address: .
Pokaż więcej
Źródło:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2024 Feb 01; Vol. 193, pp. 106673. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Journal Article
MeSH Terms:
Cyclosporine*/pharmacology
COVID-19*
Humans ; Micelles ; SARS-CoV-2 ; Nasal Sprays ; Drug Carriers ; Polyethylene Glycols ; Antiviral Agents/pharmacology
Czasopismo naukowe
Tytuł:
Cyclosporine A Does Not Mitigate Liver Ischemia/Reperfusion Injury in an Ex Vivo Porcine Model of Donation After Circulatory Death.
Autorzy:
Hefler J; Department of Surgery, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Hatami S; Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.; Canadian Donation & Transplantation Research Program, Edmonton, Alberta, Canada.
Thiesen A; Department of Laboratory Medicine & Pathology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Wagner MJ; Department of Surgery, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Mainardi G; Department of Surgery, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Himmat S; Department of Surgery, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Karvellas CJ; Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Bigam DL; Department of Surgery, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Freed DH; Department of Surgery, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.; Canadian Donation & Transplantation Research Program, Edmonton, Alberta, Canada.
Shapiro AMJ; Department of Surgery, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.; Canadian Donation & Transplantation Research Program, Edmonton, Alberta, Canada.; Clinical Islet Transplant Program, University of Alberta, Edmonton, Alberta, Canada.
Pokaż więcej
Źródło:
Annals of transplantation [Ann Transplant] 2024 Jan 30; Vol. 29, pp. e941054. Date of Electronic Publication: 2024 Jan 30.
Typ publikacji:
Journal Article
MeSH Terms:
Cyclosporine*/pharmacology
Cyclosporine*/therapeutic use
Reperfusion Injury*/pathology
Swine ; Animals ; Liver/pathology ; Perfusion ; Reperfusion ; Organ Preservation/methods
Czasopismo naukowe
Tytuł:
Conjunctival and nasal microflora in patients on topical cyclosporine for dry eye.
Autorzy:
Elibol ES; Department Of Ophtalmology, Bahçeşehir University, Göztepe Medikalpark Hospital, İstanbul, Turkey.
Habip Z; Medeniyet University, Göztepe Training and Research Hospital, Medical Microbiology Department, İstanbul, Turkey.; Department Of Ophtalmology, Göztepe Training and Research Hospital, Medeniyet University, İstanbul, Turkey.
Elbay A; Department Of Ophtalmology, Bezmialem University, İstanbul, Turkey.
Cırık AA; Department Of Otorhinolaringology, Ümraniye Training and Research Hospital, Sağlık Bilimleri University, İstanbul, Turkey.
Oğuz H; Medeniyet University, Göztepe Training and Research Hospital, Medical Microbiology Department, İstanbul, Turkey.; Department Of Ophtalmology, Göztepe Training and Research Hospital, Medeniyet University, İstanbul, Turkey.
Pokaż więcej
Źródło:
International journal of immunopathology and pharmacology [Int J Immunopathol Pharmacol] 2024 Jan-Dec; Vol. 38, pp. 3946320241227103.
Typ publikacji:
Journal Article
MeSH Terms:
Cyclosporine*
Dry Eye Syndromes*/chemically induced
Humans ; Cross-Sectional Studies ; Ophthalmic Solutions ; Anti-Bacterial Agents
Czasopismo naukowe
Tytuł:
Exploring the Effects of Cyclosporin A to Isocyclosporin A Rearrangement on Ion Mobility Separation.
Autorzy:
Mácha H; Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague 142 00, Czech Republic.; Department of Analytical Chemistry, Faculty of Science, Palacký University, 17. listopadu 12, Olomouc 771 46, Czech Republic.
Zápal J; Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague 142 00, Czech Republic.
Kuzma M; Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague 142 00, Czech Republic.; Department of Analytical Chemistry, Faculty of Science, Palacký University, 17. listopadu 12, Olomouc 771 46, Czech Republic.
Luptáková D; Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague 142 00, Czech Republic.
Lemr K; Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague 142 00, Czech Republic.; Department of Analytical Chemistry, Faculty of Science, Palacký University, 17. listopadu 12, Olomouc 771 46, Czech Republic.
Havlíček V; Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague 142 00, Czech Republic.; Department of Analytical Chemistry, Faculty of Science, Palacký University, 17. listopadu 12, Olomouc 771 46, Czech Republic.
Pokaż więcej
Źródło:
Analytical chemistry [Anal Chem] 2024 Mar 12; Vol. 96 (10), pp. 4163-4170. Date of Electronic Publication: 2024 Mar 02.
Typ publikacji:
Journal Article
MeSH Terms:
Cyclosporine*/chemistry
Peptides*/chemistry
Cyclosporins*
Ions ; Isomerism
Czasopismo naukowe
Tytuł:
Anti-psoriatic characteristics of ROCEN (topical Arthrocen) in comparison with Cyclosporine A in a murine model.
Autorzy:
Goudarzi R; Division of Research and Development, Pharmin USA, LLC, San Jose, CA, USA.
Min-Ho Kim; Department of Biological Sciences, Kent State University, Kent, OH, 44240, USA.
Partoazar A; Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło:
BMC complementary medicine and therapies [BMC Complement Med Ther] 2024 Feb 24; Vol. 24 (1), pp. 100. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Cyclosporine*/pharmacology
Psoriasis*/drug therapy
Animals ; Mice ; Disease Models, Animal ; Skin/pathology ; Cytokines/metabolism ; Imiquimod/adverse effects
Czasopismo naukowe
Tytuł:
High-abundance peaks and peak clusters associate with pharmaceutical polymers and excipients in urinary untargeted clinical metabolomics data: exploration of their origin and possible impact on label-free quantification.
Autorzy:
Klont F; Unit of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. .; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands.; Life Sciences Mass Spectrometry, Department of Inorganic and Analytical Chemistry, University of Geneva, Quai Ernest Ansermet 24, 1211 Geneva, Switzerland.
Nijdam FB; Unit of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. .
Bakker SJL; Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands.
Keski-Rahkonen P; Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Avenue Tony Garnier 25, 69007 Lyon, France.
Hopfgartner G; Life Sciences Mass Spectrometry, Department of Inorganic and Analytical Chemistry, University of Geneva, Quai Ernest Ansermet 24, 1211 Geneva, Switzerland.
Investigators T; Group of Authors on Behalf of the Transplant Lines Biobank and Cohort Study, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands.
Pokaż więcej
Źródło:
The Analyst [Analyst] 2024 Feb 12; Vol. 149 (4), pp. 1061-1067. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Excipients*/chemistry
Cyclosporine*
Humans ; Polymers ; Cohort Studies ; Polyethylene Glycols/chemistry ; Metabolomics/methods
Czasopismo naukowe
Tytuł:
The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients.
Autorzy:
Zhai Q; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Moes DJAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
van Gelder T; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
van der Lee M; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Sanders JS; Department of Nephrology, University Medical Center Groningen, Groningen, The Netherlands.
Bemelman FJ; Department of Nephrology, Academic Medical Center, Amsterdam, The Netherlands.
de Fijter JW; Department of Nephrology, Antwerp University Medical Center, Edegem, Belgium.
Klein K; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; Departments of Clinical Pharmacology, and Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany.
Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; Departments of Clinical Pharmacology, and Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany.
Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2024 Feb; Vol. 17 (2), pp. e13729.
Typ publikacji:
Journal Article
MeSH Terms:
Cyclosporine*/pharmacokinetics
Kidney Transplantation*/adverse effects
Male ; Humans ; Cytochrome P-450 CYP3A/genetics ; Immunosuppressive Agents/pharmacokinetics ; Transcription Factors/genetics ; Prospective Studies ; Genotype ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł:
Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials.
Autorzy:
McQuilten Z; Department of Haematology, Monash Health, Melbourne, Victoria, Australia .; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Heritier S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Fox L; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre & The Royal Melbourne Hospital, Parkville, Victoria, Australia.
Fox V; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Young L; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Blombery P; Department of Clinical Haematology, Peter MacCallum Cancer Centre & The Royal Melbourne Hospital, Parkville, Victoria, Australia.; University of Melbourne, Melbourne, Victoria, Australia.
Cunningham I; Concord Repatriation General Hospital, Sydney, New South Wales, Australia.; University of Sydney, Sydney, New South Wales, Australia.
Curnow J; Department of Haematology, Westmead Hospital, Sydney, New South Wales, Australia.
Higgins A; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Hiwase DK; Department of Haematology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.; South Australian Health & Medical Research Institute, Adelaide, South Australia, Australia.
Filshie R; Haematology Department, St Vincent's Hospital, Melbourne, Victoria, Australia.
Firkin F; Haematology Department, St Vincent's Hospital, Melbourne, Victoria, Australia.
Lacaze P; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Mason K; Department of Clinical Haematology, Peter MacCallum Cancer Centre & The Royal Melbourne Hospital, Parkville, Victoria, Australia.
Mills AK; University of Queensland, Brisbane, Queensland, Australia.; Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Pepperell D; Department of Haematology, Fiona Stanley Hospital, Murdoch, Perth, Australia.
Patil S; Department of Haematology, Alfred Hospital, Melbourne, Victoria, Australia.
Stevenson W; Department of Haematology, Royal North Shore Hospital, St Leonards, Sydney, Australia.
Szer J; Department of Clinical Haematology, Peter MacCallum Cancer Centre & The Royal Melbourne Hospital, Parkville, Victoria, Australia.; University of Melbourne, Melbourne, Victoria, Australia.
Waters N; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Wilson K; University of Sydney, Sydney, New South Wales, Australia.
Ting S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Department of Haematology, Eastern Health, Melbourne, Victoria, Australia.
Wood E; Department of Haematology, Monash Health, Melbourne, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2024 Jan 18; Vol. 14 (1), pp. e076246. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cyclosporine*/therapeutic use
Anemia, Aplastic*/drug therapy
Hydrazines*
Benzoates*
Thiophenes*
Pyrazoles*
Thiazoles*
Humans ; Animals ; Horses ; Immunosuppressive Agents/adverse effects ; Bayes Theorem ; Antilymphocyte Serum/therapeutic use ; Immunosuppression Therapy ; Treatment Outcome ; Clinical Trials, Phase II as Topic
Czasopismo naukowe
Tytuł:
Pharmacokinetic Parameters of Recombinant Human Cyclophilin A in Mice.
Autorzy:
Kalinina A; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Kashirskoe sh. 24, 115478, Moscow, Russian Federation.
Grigorieva E; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Kashirskoe sh. 24, 115478, Moscow, Russian Federation.
Smirnova A; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Kashirskoe sh. 24, 115478, Moscow, Russian Federation.
Kazansky D; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Kashirskoe sh. 24, 115478, Moscow, Russian Federation.
Khromykh L; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Kashirskoe sh. 24, 115478, Moscow, Russian Federation. .
Pokaż więcej
Źródło:
European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2024 Jan; Vol. 49 (1), pp. 57-69. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
Cyclophilin A*/metabolism
Cyclophilin A*/pharmacokinetics
Cyclosporine*/pharmacology
Animals ; Female ; Humans ; Mice ; Kidney/metabolism ; Tissue Distribution ; Recombinant Proteins/pharmacokinetics
Czasopismo naukowe
Tytuł:
Systemic anti-inflammatory treatment of atopic dermatitis during conception, pregnancy and breastfeeding: Interdisciplinary expert consensus in Northern Europe.
Autorzy:
Deleuran M; Department of Dermatology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.
Dézfoulian B; Dermatology Department, Liège University Hospital, Liège, Belgium.
Elberling J; Department of Dermatology and Allergy, Department of Clinical Medicine, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Knutar I; Department of Dermatology, Vaasa Central Hospital, Vaasa, Finland.
Lapeere H; Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
Lossius AH; Department of Dermatology, Oslo University Hospital, Oslo, Norway.
Schuttelaar MLA; Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Stockman A; Department of Dermatology, AZ Delta, Torhout, Belgium.
Wikström E; Dermatology Health Clinic, Oulu, Finland.
Bradley M; Dermatology and Venereology Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Solna, Sweden.
de Bruin-Weller M; Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
Gutermuth J; Vrije Universiteit Brussel (VUB), SKIN Research Group, Department of Dermatology, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Mandelin JM; Department of Dermatology, Helsinki University Central Hospital, Helsinki, Finland.
Schmidt MC; Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark.
Thyssen JP; Department of Dermatology and Venereology, Bispebjerg Hospital, Copenhagen, Denmark.
Vestergaard C; Department of Dermatology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.
Pokaż więcej
Źródło:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Jan; Vol. 38 (1), pp. 31-41. Date of Electronic Publication: 2023 Oct 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cyclosporine*/therapeutic use
Dermatitis, Atopic*/drug therapy
Pregnancy ; Male ; Humans ; Female ; Methotrexate/therapeutic use ; Breast Feeding ; Azathioprine/therapeutic use ; Mycophenolic Acid/therapeutic use ; Consensus ; Anti-Inflammatory Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Bimetallic metal-organic framework as an efficient sorbent for the extraction of tacrolimus and cyclosporine from plasma before HPLC-MS/MS analysis.
Autorzy:
Mehrvarz F; Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
Dehghan G; Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran. Electronic address: .
Afshar Mogaddam MR; Food and Drug Safety Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Pharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: .
Pokaż więcej
Źródło:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2023 Dec 01; Vol. 1231, pp. 123907. Date of Electronic Publication: 2023 Nov 04.
Typ publikacji:
Journal Article
MeSH Terms:
Cyclosporine*
Metal-Organic Frameworks*/chemistry
Humans ; Tacrolimus ; Chromatography, High Pressure Liquid/methods ; Tandem Mass Spectrometry/methods ; Solid Phase Extraction
Czasopismo naukowe
Tytuł:
NOVATIVE: A Phase II/III, Multicenter, Double-masked, Randomized Study of Cyclosporine A 0.05% and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients with Vernal Keratoconjunctivitis.
Autorzy:
Leonardi A; Department of Neuroscience, University of Padua, Padua, Italy.
Pisella PJ; Department of Ophthalmology, Tours University Hospital, Université François Rabelais, Hôpital Bretonneau, Tours, France.
Benítez-Del-Castillo JM; Department of Ophthalmology, Hospital Clinico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria del Hospital Clinico San-Carlos (IdISSC), Madrid, Spain; Clínica Rementería, Madrid, Spain.
Amrane M; Santen SAS, Évry-Courcouronnes, France.
Ismail D; Santen SAS, Évry-Courcouronnes, France.
Doan S; Department of Ophthalmology, Fondation A de Rothchild, Paris, France.
Bremond-Gignac D; University Hospital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France; Rare Eye Disease Center (OPHTARA), Paris Cite University, Paris, France. Electronic address: .
Pokaż więcej
Źródło:
Clinical therapeutics [Clin Ther] 2023 Dec; Vol. 45 (12), pp. 1284-1288. Date of Electronic Publication: 2023 Oct 21.
Typ publikacji:
Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Conjunctivitis, Allergic*/drug therapy
Cyclosporine*/therapeutic use
Keratitis*/drug therapy
Humans ; Double-Blind Method ; Emulsions/therapeutic use ; Ophthalmic Solutions/therapeutic use ; Pruritus ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Reaching the cyclosporine a level target slowly in four weeks correlates with better prognosis for Chinese patients after allogeneic haematopoietic cell transplantation.
Autorzy:
Fan Q; Department of Pharmacy, Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University), Nanjing, People's Republic of China.
Hui X; Department of Pharmacy, Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University), Nanjing, People's Republic of China.
Li X; Department of Pharmacy, Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University), Nanjing, People's Republic of China.
Li Q; Department of Pharmacy, Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University), Nanjing, People's Republic of China.
Yang D; Department of Pharmacy, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, People's Republic of China.
Wang Y; Department of Pharmacy, Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University), Nanjing, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2275893. Date of Electronic Publication: 2023 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
Cyclosporine*/therapeutic use
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; East Asian People ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Improved LC-MS/MS method for the simultaneous quantification of tacrolimus and cyclosporine A in human blood and application to therapeutic drug monitoring.
Autorzy:
Chen F; Department of Clinical Pharmacy, Hunan University of Medicine General Hospital, Huaihua, China.
Yang X; Department of Endocrine Metabolism and Clinical Nutrition, Hunan University of Medicine General Hospital, Huaihua, China.
Li H; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.; School of Pharmacy, Queen's University Belfast, Belfast, UK.
Zeng X; Department of Clinical Pharmacy, Hunan University of Medicine General Hospital, Huaihua, China.; Department of Evidence-Based Medicine and Clinical Center, Hunan University of Medicine General Hospital, Huaihua, China.
Deng Z; Department of Clinical Pharmacy, Hunan University of Medicine General Hospital, Huaihua, China.; Department of Evidence-Based Medicine and Clinical Center, Hunan University of Medicine General Hospital, Huaihua, China.
Wang H; Department of Clinical Pharmacy, Hunan University of Medicine General Hospital, Huaihua, China.; Department of Evidence-Based Medicine and Clinical Center, Hunan University of Medicine General Hospital, Huaihua, China.
Jin Y; Department of Clinical Pharmacy, Hunan University of Medicine General Hospital, Huaihua, China.; Department of Evidence-Based Medicine and Clinical Center, Hunan University of Medicine General Hospital, Huaihua, China.
Qiu C; Department of Clinical Pharmacy, Hunan University of Medicine General Hospital, Huaihua, China.; Department of Evidence-Based Medicine and Clinical Center, Hunan University of Medicine General Hospital, Huaihua, China.
Shi Z; Department of Clinical Pharmacy, Hunan University of Medicine General Hospital, Huaihua, China.; Department of Evidence-Based Medicine and Clinical Center, Hunan University of Medicine General Hospital, Huaihua, China.
Pokaż więcej
Źródło:
Biomedical chromatography : BMC [Biomed Chromatogr] 2023 Dec; Vol. 37 (12), pp. e5751. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:
Journal Article
MeSH Terms:
Cyclosporine*
Tacrolimus*
Humans ; Chromatography, Liquid/methods ; Drug Monitoring/methods ; Tandem Mass Spectrometry/methods ; Chromatography, High Pressure Liquid/methods
Czasopismo naukowe
Tytuł:
A single-centre prospective study comparing efficacy and safety of apremilast with cyclosporine in moderate to severe atopic dermatitis.
Autorzy:
Vyas HR; Department of Dermatology, Venerology and Leprology, B.J. Medical College and Civil Hospital Ahmedabad, Ahmedabad, India.
Shah SR; Department of Dermatology, Venerology and Leprology, B.J. Medical College and Civil Hospital Ahmedabad, Ahmedabad, India.
Shah BJ; Department of Dermatology, Venerology and Leprology, B.J. Medical College and Civil Hospital Ahmedabad, Ahmedabad, India.
Parmar KS; Department of Dermatology, Venerology and Leprology, B.J. Medical College and Civil Hospital Ahmedabad, Ahmedabad, India.
Jangid N; Department of Dermatology, Venerology and Leprology, B.J. Medical College and Civil Hospital Ahmedabad, Ahmedabad, India.
Choudhary A; Department of Dermatology, Venerology and Leprology, B.J. Medical College and Civil Hospital Ahmedabad, Ahmedabad, India.
Gehlawat T; Department of Dermatology, Venerology and Leprology, B.J. Medical College and Civil Hospital Ahmedabad, Ahmedabad, India.
Mistry D; Department of Dermatology, Venerology and Leprology, B.J. Medical College and Civil Hospital Ahmedabad, Ahmedabad, India.
Pokaż więcej
Źródło:
The Australasian journal of dermatology [Australas J Dermatol] 2023 Nov; Vol. 64 (4), pp. e333-e339. Date of Electronic Publication: 2023 Jul 24.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Cyclosporine*/adverse effects
Dermatitis, Atopic*/drug therapy
Humans ; Prospective Studies ; Severity of Illness Index ; Treatment Outcome ; Immunoglobulin A ; Double-Blind Method
Czasopismo naukowe
Tytuł:
This Month in JAAD Case Reports: December 2023 - Topical cyclosporine for pyoderma gangrenosum.
Autorzy:
Sloan B; Department of Dermatology, University of Connecticut School of Medicine, Farmington, Connecticut. Electronic address: .
Pokaż więcej
Źródło:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 Dec; Vol. 89 (6), pp. 1125. Date of Electronic Publication: 2023 Sep 27.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Cyclosporine*/therapeutic use
Pyoderma Gangrenosum*/drug therapy
Humans
Opinia redakcyjna
Tytuł:
The effects of pretreatment with Cyclosporin A and Docetaxel before vitrification of porcine immature oocytes on subsequent embryo development.
Autorzy:
Nguyen HT; Institute of Biotechnology (IBT), Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam.
Nguyen NT; Institute of Biotechnology (IBT), Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam.
Nguyen LV; Institute of Biotechnology (IBT), Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam.
Bui XN; Institute of Biotechnology (IBT), Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam.
Nguyen VH; Institute of Biotechnology (IBT), Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam.
Nguyen VK; Key Lab of Animal Cell Biotechnology, National Institute of Animal Science (NIAS), Hanoi, Vietnam.
Vu HTT; Key Lab of Animal Cell Biotechnology, National Institute of Animal Science (NIAS), Hanoi, Vietnam.
Nguyen ST; Institute of Biotechnology (IBT), Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam.
Nguyen HT; Institute of Biotechnology (IBT), Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam. Electronic address: .
Pokaż więcej
Źródło:
Reproductive biology [Reprod Biol] 2023 Dec; Vol. 23 (4), pp. 100798. Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:
Journal Article
MeSH Terms:
Vitrification*
Cyclosporine*/pharmacology
Swine ; Animals ; Docetaxel/pharmacology ; Cryopreservation/veterinary ; Oocytes ; Embryonic Development
Czasopismo naukowe
Tytuł:
Are cyclosporine eye drops a suitable treatment in ocular rosacea?
Autorzy:
Prados-Carmona A; Department of Dermatology, Hospital Universitario San Cecilio, Granada, Spain.
Prados-Carmona JJ; Department of Ophthalmology, Hospital Universitario Reina Sofía, Córdoba, Spain.
Gálvez-Moreno M; Department of Dermatology, Hospital Universitario San Cecilio, Granada, Spain.
Ruiz-Villaverde R; Department of Dermatology, Hospital Universitario San Cecilio, Granada, Spain.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2135964. Date of Electronic Publication: 2022 Oct 19.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Cyclosporine*/therapeutic use
Rosacea*/drug therapy
Humans ; Ophthalmic Solutions/therapeutic use ; Immunosuppressive Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Comparison of matrix metallopeptidase-9 expression following cyclosporine and diquafosol treatment in dry eye.
Autorzy:
So HR; Department of Ophthalmology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Gyeonggi-do, Korea.
Baek J; Department of Ophthalmology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Gyeonggi-do, Korea.
Lee JY; Department of Ophthalmology, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea.
Kim HS; Department of Ophthalmology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim MS; Department of Ophthalmology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim EC; Department of Ophthalmology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Gyeonggi-do, Korea.; Department of Ophthalmology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Pokaż więcej
Źródło:
Annals of medicine [Ann Med] 2023 Dec; Vol. 55 (1), pp. 2228192.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cyclosporine*/therapeutic use
Dry Eye Syndromes*/drug therapy
Humans ; Matrix Metalloproteinase 9 ; Uracil Nucleotides/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies